Introduction: Audit report and follow-up MCQs With Answer is designed specifically for M.Pharm students studying Documentation & Regulatory Writing. This quiz set focuses on the principles of preparing clear, compliant audit reports and executing effective follow-up actions including CAPA, root cause analysis, verification, and closure. Questions emphasize regulatory expectations, report components, classification of findings, evidence requirements, timelines, and quality unit responsibilities. Practicing these MCQs helps students deepen their understanding of how audit outcomes translate into corrective strategies, regulatory responses, and continual improvement in pharmaceutical quality systems—essential skills for roles in QA, regulatory affairs, and manufacturing compliance.
Q1. What is the primary objective of an audit report in a pharmaceutical quality system?
- To provide a legal defense against regulatory action
- To document observations and recommend corrective and preventive actions to ensure compliance and product quality
- To replace management review documentation
- To disclose all internal financial data
Correct Answer: To document observations and recommend corrective and preventive actions to ensure compliance and product quality
Q2. Which of the following is an essential element that must be included in an audit report?
- Personal opinions about individual staff performance
- Scope, criteria, findings with evidence, conclusions and recommended actions
- Confidential supplier financial statements
- Only positive observations to encourage staff
Correct Answer: Scope, criteria, findings with evidence, conclusions and recommended actions
Q3. How are audit findings commonly categorized to reflect their impact on product quality and compliance?
- Minor, Major, Critical and Observation
- Low, Medium, High and Financial
- Administrative, Technical, Managerial, and Legal
- Informal, Formal, Urgent, and Optional
Correct Answer: Minor, Major, Critical and Observation
Q4. What distinguishes an “observation” from a “nonconformity” in audit terminology?
- An observation always requires immediate product recall
- An observation indicates potential weakness or opportunity for improvement; a nonconformity indicates a requirement is not met
- An observation is written by management; a nonconformity is written by auditors
- There is no difference; the terms are interchangeable
Correct Answer: An observation indicates potential weakness or opportunity for improvement; a nonconformity indicates a requirement is not met
Q5. When establishing timelines for corrective actions (CAPA) after an audit, the best practice is to:
- Set a uniform 90-day deadline for all findings regardless of severity
- Define timeframes based on risk assessment and severity of the finding
- Allow the auditee to decide without oversight
- Only act after the next external regulatory inspection
Correct Answer: Define timeframes based on risk assessment and severity of the finding
Q6. Who is primarily responsible for verifying the effectiveness of corrective actions and approving closure of audit findings?
- The auditee’s immediate supervisor without documentation review
- The Quality Assurance/Quality Unit or designated verifier who reviews evidence of implementation and effectiveness
- The external auditor who performed the audit, always
- Any staff member assigned by the auditee
Correct Answer: The Quality Assurance/Quality Unit or designated verifier who reviews evidence of implementation and effectiveness
Q7. What type of evidence is required to justify closure of a corrective action for a major nonconformity?
- Oral confirmation from an operator
- Documented evidence of implementation plus objective evidence of effectiveness such as test results, trend data or verification records
- A single photo without context
- A signed memo stating the problem is solved without records
Correct Answer: Documented evidence of implementation plus objective evidence of effectiveness such as test results, trend data or verification records
Q8. Which root cause analysis techniques are commonly used in pharmaceutical audit follow-up to identify underlying causes?
- Simple assumption and anecdotal reasoning
- 5 Whys, Fishbone (Ishikawa), and fault-tree analysis
- Coin toss and majority voting
- Only external consultant reports without internal review
Correct Answer: 5 Whys, Fishbone (Ishikawa), and fault-tree analysis
Q9. The primary purpose of a re-audit after closure of corrective actions is to:
- Assign blame to the original team
- Verify that corrective actions were implemented and are effective in preventing recurrence
- Issue new nonconformities to increase audit activity
- Reduce training requirements for staff
Correct Answer: Verify that corrective actions were implemented and are effective in preventing recurrence
Q10. To whom should the final audit report normally be distributed within the organization?
- Only the auditee’s team members
- Auditee, Quality Assurance/Quality Unit, relevant department heads and management for action
- All employees including external contractors without need-to-know
- Only external regulatory authorities
Correct Answer: Auditee, Quality Assurance/Quality Unit, relevant department heads and management for action
Q11. Why is trending of audit findings useful for a pharmaceutical quality system?
- It replaces the need for root cause analysis
- It helps identify systemic problems, recurring issues and areas needing process improvement
- It increases the number of nonconformities to justify more audits
- It is useful only for financial forecasting
Correct Answer: It helps identify systemic problems, recurring issues and areas needing process improvement
Q12. How does a regulatory inspection differ from an internal audit in the pharmaceutical industry?
- An internal audit is legally binding while regulatory inspections are optional
- Regulatory inspections are performed by external authority and can result in enforcement actions; internal audits are internal compliance checks aimed at improvement
- Regulatory inspections do not document findings
- Internal audits always lead to product recalls
Correct Answer: Regulatory inspections are performed by external authority and can result in enforcement actions; internal audits are internal compliance checks aimed at improvement
Q13. When scoring the severity of a nonconformity, the most appropriate basis is:
- The personal opinion of the auditor only
- The assessed risk to product quality and patient safety combined with regulatory and process impact
- The size of the department involved
- The popularity of the auditee among peers
Correct Answer: The assessed risk to product quality and patient safety combined with regulatory and process impact
Q14. Complete documentation for audit follow-up should typically include:
- Only a short email confirming actions
- CAPA plan with responsibilities and timelines, implementation records, verification evidence and closure approval
- Photocopies of unrelated invoices
- Verbal promises recorded in a meeting without minutes
Correct Answer: CAPA plan with responsibilities and timelines, implementation records, verification evidence and closure approval
Q15. Who should formally sign off the final audit report before distribution in a GMP environment?
- The lead auditor and/or designated Quality Unit representative as per the audit procedure
- The auditee’s direct reports only
- Any random employee available at the time
- No signature is required for official reports
Correct Answer: The lead auditor and/or designated Quality Unit representative as per the audit procedure
Q16. In which situation is immediate notification to senior management and QA usually required after an audit?
- When an observation relates to an administrative spelling error
- When a critical finding compromises patient safety, product quality or regulatory compliance
- When a minor housekeeping issue is noted
- When the auditee requests more training materials
Correct Answer: When a critical finding compromises patient safety, product quality or regulatory compliance
Q17. What is the difference between verification and validation when closing audit corrective actions?
- Verification confirms the action was implemented; validation confirms the action is effective in achieving the intended outcome
- Verification is optional but validation is mandatory for all actions
- They are the same activity with different names
- Verification always requires external consultants while validation does not
Correct Answer: Verification confirms the action was implemented; validation confirms the action is effective in achieving the intended outcome
Q18. How long should audit reports and follow-up CAPA records generally be retained?
- Until the next audit only
- Per company policy and applicable regulatory requirements, typically aligned with product records retention and GMP requirements
- One week after closure
- Only until management approves their destruction
Correct Answer: Per company policy and applicable regulatory requirements, typically aligned with product records retention and GMP requirements
Q19. What is the recommended approach to prioritize multiple audit findings for action planning?
- Address findings alphabetically by department name
- Use a risk-based prioritization considering severity, frequency and detectability
- Work on the easiest items first regardless of impact
- Always defer to external consultants for prioritization
Correct Answer: Use a risk-based prioritization considering severity, frequency and detectability
Q20. Is it acceptable to close an audit observation solely on the basis of documented action without evidence of effectiveness?
- Yes, documentation alone is sufficient for closure
- No, closure requires documented implementation plus objective evidence demonstrating effectiveness in preventing recurrence
- Only if the auditee signs a statement of intent
- Yes, if the action was expensive
Correct Answer: No, closure requires documented implementation plus objective evidence demonstrating effectiveness in preventing recurrence
